loperamide in 7 month old
Reading File
Finding Sources
Searching PubMed
loperamide children safety infants
Reading File
Reading File
Here is a complete, evidence-based answer:
Loperamide in a 7-Month-Old Infant
Bottom Line: Do Not Use
Loperamide is contraindicated in children under 2 years of age, including a 7-month-old infant. This is a firm, well-established clinical recommendation from regulatory agencies and standard pharmacology references.
Why It Is Contraindicated in Infants
1. CNS Depression Risk
At therapeutic doses, loperamide is designed to stay out of the CNS in adults because of active efflux by P-glycoprotein (Pgp) at the blood-brain barrier. In young infants, the blood-brain barrier is immature and Pgp expression is low, meaning loperamide can penetrate into the brain and cause:
- Sedation and CNS depression
- Respiratory depression
- Coma
(Goodman & Gilman's Pharmacological Basis of Therapeutics - confirms "not recommended for use in children younger than 2 years")
2. Paralytic Ileus
Overdosage - which is easily reached in infants given their small body weight - can cause paralytic ileus, a life-threatening complication.
3. Cardiotoxicity
The FDA has placed a black box warning on loperamide noting that exceeding recommended dosage causes:
- QT prolongation (torsades de pointes)
- QRS widening
- Ventricular tachycardia / ventricular fibrillation
- Cardiac arrest and death
The margin between a "therapeutic dose" and a toxic dose in a 7-month-old infant is extremely narrow.
4. Deaths Have Been Reported
Multiple infant fatalities associated with loperamide use prompted the FDA to strengthen warnings and restrict its use. The WHO's oral rehydration therapy (ORT) guidelines specifically exclude antimotility agents for children under 5.
What to Use Instead for Diarrhea in a 7-Month-Old
The standard of care for acute diarrhea in a 7-month-old is:
| Intervention | Details |
|---|---|
| Oral Rehydration Solution (ORS) | First-line; WHO/UNICEF low-osmolarity ORS (replace losses) |
| Continued feeding | Do not withhold breast milk or formula; early refeeding shortens illness |
| Zinc supplementation | 10 mg/day for infants <6 months; 20 mg/day for infants >6 months for 10-14 days (WHO recommendation) |
| Probiotics | Some evidence for Lactobacillus rhamnosus GG and Saccharomyces boulardii shortening duration |
| Antibiotics | Only if a specific bacterial or parasitic cause is identified (e.g., cholera, Shigella) |
Do NOT use: Loperamide, diphenoxylate, kaolin-pectin, or bismuth subsalicylate in this age group.
Key References
- Goodman & Gilman's Pharmacological Basis of Therapeutics, 14th ed. - "Loperamide is not recommended for use in children younger than 2 years. Overdosage can result in constipation, CNS depression (especially in children), and paralytic ileus."
- FDA Drug Safety Communication on Loperamide - Black box warning for cardiac events
If this is a clinical emergency (infant has already received loperamide), monitor for respiratory depression, CNS sedation, and cardiac arrhythmias. Naloxone can reverse respiratory depression, and sodium bicarbonate (1-2 mEq/kg IV) is used for QRS widening due to sodium channel blockade.
This is a shared conversation. Sign in to Orris to start your own chat.